The Next Generation of Low Dead Space Disposable Syringes
Healthcare has transformed nearly every aspect of patient care over the past several decades. Hospitals now use robotic surgery, smart infusion pumps, artificial intelligence, electronic medication administration records, and advanced biologic therapies.
Yet one of the most commonly used medical devices the disposable syringe has remained fundamentally unchanged.
The QD Syringe Platform was developed to rethink medication preparation from the ground up. Rather than asking healthcare professionals to adapt to the limitations of traditional syringe design, the QD Platform was created to simplify workflow, reduce medication waste, and improve efficiency through a functional, low dead-space syringe architecture.
Here are 25 ways the QD Syringe was designed to improve medication preparation.
Unlike conventional syringes that typically require a separate draw needle or vial access device before medication can be withdrawn, the QD Syringe incorporates an integrated medication preparation cannula.
The QD Syringe was engineered with a low dead-space objective to reduce residual medication remaining after injection, helping maximize medication delivery.
Reducing dead space may decrease waste of expensive injectable medications, particularly biologics, oncology drugs, specialty pharmaceuticals, and hormone therapies.
The integrated cannula eliminates the need for a separate steel draw needle during medication preparation.
Fewer accessory devices may reduce medication preparation steps for pharmacists, nurses, and other clinicians.
Unlike many low dead space syringes that rely on permanently attached needles, the QD Platform incorporates a detachable low dead space injection hub.
The integrated cannula is intended specifically for vial access, separating medication preparation from patient injection.
Because the injection needle is not used to penetrate rubber vial stoppers, its tip and lubricant coating remain intact prior to patient use.
Preserving needle integrity before injection may help optimize needle performance. Clinical studies would be needed to quantify any effect on patient comfort.
The QD Cannula incorporates bilateral side channels designed to facilitate medication withdrawal from rubber stopper vials.
The integrated cannula was designed with the goal of improving access to medication throughout the vial while reducing repeated manipulation.
The platform supports medication reconstitution workflows while reducing dependence on additional vial access devices.
The QD concept has potential applications in radiopharmaceutical preparation, where minimizing medication waste and simplifying workflow are particularly valuable.
The platform addresses common workflow challenges associated with repeatedly drawing medications from multi dose vials used in hormone replacement therapy.
Reducing medication waste may provide additional value when preparing high cost oncology medications.
Hospital pharmacies continually seek opportunities to improve efficiency. A functional syringe platform has the potential to simplify medication preparation while reducing accessory devices.
Eliminating the separate draw needle may reduce the number of sharps handled during medication preparation.
One integrated platform may reduce the number of individual products hospitals must stock and manage.
Fewer accessory devices may contribute to reductions in sharps disposal and packaging waste.
The QD Platform was designed to support multiple clinical applications, including medication preparation, injection, blood collection, and specialized procedures through dedicated hubs and accessories.
The QD Platform has been designed with compatibility in mind for medication vials and selected needleless IV systems, with compatibility depending on the specific connector design.
Rather than adapting an injection needle for medication withdrawal, the QD Cannula was designed specifically for medication preparation.
Published literature has shown that device geometry influences rubber stopper coring. The QD Cannula incorporates a non-coring design objective that would require dedicated testing to validate.
Reducing medication waste, simplifying workflow, and reducing accessory devices may provide meaningful economic benefits for healthcare systems, particularly when using high-cost injectable medications.
The QD Syringe is more than a disposable syringe.
It represents a modular medication preparation platform designed to modernize one of healthcare's most frequently used medical devices.
As injectable therapies continue to become more advanced and more expensive the systems used to prepare and deliver those medications deserve the same level of innovation.
The QD Platform was developed to challenge long standing assumptions about syringe design and to explore a future where medication preparation is safer, simpler, more efficient, and less wasteful.
While some aspects of the platform are supported by published research on low dead space and medication preparation, other design objectives will continue to benefit from bench testing, human factors studies, and clinical validation. Together, they represent a vision for the next generation of medication preparation technology.
Views: 2
Tags: Drug Delivery, Drug Waste, Functional Syringe, Healthcare Costs, Healthcare Innovation, Hormone Replacement Therapy, Hospital Pharmacy, Injectable Medications, Injection Technology, Low Dead Space, More…Low Dead Space Syringe, Medical Device Innovation, Medical Devices, Medical Engineering, Medical Technology, Medication Preparation, Medication Reconstitution, Medication Waste, Nuclear Medicine, Oncology Pharmacy, Patient Safety, Pharmacy Workflow, QD Syringe, Syringe Design, Universal Cannula
© 2026 Created by Christopher Green.
Powered by
You need to be a member of QD Syringe Systems® to add comments!
Join QD Syringe Systems®